	Interessi Passivi Sul Debito		Data
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Akebia Therapeutics	364.15M	18.56M	2025-09
ALKERMES	USD 4.65M	1.35M	2024-12
Alnylam Pharmaceuticals	USD 129.34M	84.94M	2025-12
Amarin	USD 3K	5K	2024-12
ANI Pharmaceuticals	USD 4.73M	711K	2025-09
BioMarin Pharmaceutical	USD 2.58M	100K	2025-09
Coherus Biosciences	USD 2.15M	3.2M	2025-03
Exact Sciences	USD 9.79M	46K	2025-09
Exelixis	USD 23.4M	3.9M	2023-09
Glaxosmithkline	GBP 177.95M	6.05M	2025-09
Heron Therapeutics	USD 500K	900K	2024-09
Ionis Pharmaceuticals	USD 18M	1000K	2025-09
Ironwood Pharmaceuticals	USD 8.74M	506K	2024-12
Lexicon Pharmaceuticals	USD 2.21M	2.74M	2024-06
Lonza	CHF 84M	14M	2025-06
Merck	USD 412M	85M	2025-12
Moderna	USD 12.14B	12.13B	2025-09
Myriad Genetics	USD 800K	100K	2025-03
Nektar Therapeutics	USD 6.02M	420K	2024-09
Neurocrine Biosciences	USD 1.1M	0	2024-03
Pacira	USD 4.28M	456K	2025-09
Pfizer	USD 711M	59M	2025-12
PTC Therapeutics	USD 2.64B	2.61B	2025-09
Sanofi	EUR -25M	252M	2025-12
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
United Therapeutics	USD 3M	4.3M	2025-09
Vanda Pharmaceuticals	601.14M	23.61M	2025-09
Xoma	USD 3.4M	150K	2024-06

Emergent BioSolutions Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.